Institutional Investors Control 53% of Novavax, Inc. (NASDAQ:NVAX) and Were Rewarded Last Week After Stock Increased 6.3%

Yahoo Finance26minutes ago

Novavax Analyst Ratings

BenzingaDec 10 12:11 ET · Ratings

H.C. Wainwright Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $19

Moomoo NewsDec 10 10:31 ET · Ratings

Jim Cramer Is 'Not A Fan' Of Novavax, Says This Tech Stock Is 'Expensive'

BenzingaDec 10 08:27 ET

Novavax, Inc. (NVAX) Is Attracting Investor Attention: Here Is What You Should Know

Zacks Dec 10 08:10 ET

Express News | Novavax Inc - Working With FDA on Potential Accelerated Approval

ReutersDec 10 08:00 ET